Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Metabolic syndrome, leaky guts, and infection: Metabolic syndrome often accompanies obesity and hyperglycemia and is associated with a breakdown in the integrity of the intestinal barrier and increased risk of systemic infection. Thaiss et al. found that mice with systemic infection of a Salmonella analog, Citrobacter rodentium , also exhibited hyperglycemia. Deletion of the glucose transporter GLUT2 altered sensitivity to chemically induced epithelial permeability and protected mice from pathogen invasion. The authors also found a correlation in humans between glycated hemoglobin (an indicator of hyperglycemia) and serum levels of pathogen recognition receptor ligands. Science , this issue p. 1376
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thaiss et al. clearly showed that hyperglycemia drives intestinal permeability by the glucose transporter GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells, resulting in changes in tight and adherence junction integrity, and a systemic influx of microbial products into portal blood [274].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [274]
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X., Murre, C., Singh, H., & Glass, C. K. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.004 · Cited by 13,382
TopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Inflammation, metaflammation and immunometabolic disorders
Hotamisligil, G. S. (2017) · Nature · doi:10.1038/nature21363 · Cited by 2,570
Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types
Jaitin, D. A., Kenigsberg, E., Keren-Shaul, H., Elefant, N., Paul, F., Zaretsky, I., Mildner, A., Cohen, N., Jung, S., Tanay, A., et al. (2014) · Science · doi:10.1126/science.1247651 · Cited by 1,795
Van der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684
Cited by
Items 701–800 of 965
Fang, C., Xu, X., Lü, F., & Liu, S. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1500935 · Cited by 3
Minton, K. (2018) · Nature reviews. Immunology · doi:10.1038/nri.2018.22 · Cited by 3
Effects of Running on the Development of Diabetes and Diabetes-Induced Complications
Podvigina, T. T., Yarushkina, N. I., & Filaretova, L. P. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022010161 · Cited by 4
Wang, Y., Liang, F., Liu, M., Ding, L., Hui, J., Xu, H., & Liu, L. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00943-5 · Cited by 3
“Preclinical study has confirmed that hyperglycemia can independently drive the impairment of intestinal barrier, facilitate intestinal bacteria translocation and increase the risk of enteric infection [12].”
BackgroundInfluentialMicrobiota and diabetes: an increasingly relevant association
Tilg, H., & Grander, C. (2018) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.4286 · Cited by 4
Wu, N., Yim, H. C. H., Grimm, M., & El-Omar, E. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65657-x · Cited by 3
Zou, Q., Wang, R., Dong, Y., Li, W., Zhao, G., Yin, Z., Hu, M., Li, Y., Xu, Q., Wang, L., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1606443 · Cited by 2
Zhao, L., Zhao, C., Li, A., Gao, Q., Ai, S., Wang, Y., Chen, Z., & Wang, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1671238 · Cited by 2
Xu, J., Zhang, Q., Wang, Z., Liu, S., Zhu, S., Zhang, S., & Wu, S. (2025) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002264 · Cited by 2
Prebiotic dietary fibre from marine seaweed: A potential treatment strategy for type 2 diabetes
Gopal, R. K., Ganesh, P. S., & Pathoor, N. N. (2025) · Algal Research · doi:10.1016/j.algal.2025.104368 · Cited by 2
Mukherjee, K., Guest, P. C., Nussbaumer, M., Dudeck, L., Asl, L. S., Meyer-Lotz, G., Dobrowolny, H., Borucki, K., Bernstein, H., Link, A., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03584-3 · Cited by 2
“Elevated glucose levels disrupt tight junctions through GLUT2-mediated metabolic reprogramming in intestinal epithelial cells, increasing paracellular permeability [56, 57].”
Microbiota–Drug Interaction and Its Influence on Drug Metabolism and Toxicity
Pal, R., Bhowmick, P., Mahanty, J., Halder, P., & Bhowmick, M. (2025) · Interdisciplinary biotechnological advances · doi:10.1007/978-981-95-2104-3_3 · Cited by 3
Sun, Y., Bai, X., Sun, K., Li, J., Liu, L., Chen, Y.-Y., Zeng, Z.-Y., Wang, Q., & Guo, Y. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i42.111706 · Cited by 2
Bridging gut microbiota and renal health: Klotho as a promising therapeutic agent in DKD
Rakshe, P. S., & Gaikwad, A. B. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04897-z · Cited by 2
Phlorizin-integrated magnetic pollen micromotors for diabetes complication management
Zhou, M., Yang, X., Li, H., & Shang, L. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102582 · Cited by 2
“The cause can be attributed to the impacts of long-term hyperglycemia on the immune system, intestinal barrier function, and intestinal flora [12,13].”
Zhang, R., Wang, H., Wei, G., Sun, X., Zou, Y., Wen, C., Li, T., Yi, H., & Tong, L. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.167226 · Cited by 2
Du, Q., Li, Q., Ullah, H., Wei, Y., Liao, G., Xiao, X., Yao, J., & Li, K. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-00922-y · Cited by 3
“This allows harmfulsubstanceslikeLPStocrossthebarrier,activatepatternrecognition receptors(e.g.,TLRsandNLRs),andtriggerin fl ammatory responses 31 .”
Fang, Z., Liu, Z., Pu, Z., Xia, Q., Zhang, Q., Wang, L., Jia, P., & Tang, X. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1707035 · Cited by 4
Pathological effects of diabetic mice with Helicobacter pylori infection
Yang, W.-P., Zeng, J.-H., Wu, B.-L., Zhou, W.-T., Luo, J.-Z., Dai, Y.-Y., Yang, S.-X., Huang, Z.-S., & Huang, Y.-Q. (2026) · World Journal of Diabetes · doi:10.4239/wjd.v17.i2.112534 · Cited by 2
Tan, F., Zheng, L., Yuan, D., Wang, S., Yao, W., Wang, T., Xia, B., Li, N., Zhang, F., Chen, T., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.02.042 · Cited by 2
Kaur, G., & Kushwah, A. S. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10765-8 · Cited by 2
Yu, Z., Ma, H., Zhang, H., Gao, L., Fu, X., Wang, H., Xiao, Y., Wu, X., Zhang, A., Kang, Y., et al. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1779459 · Cited by 2
Xie, W., Yuan, J., Feng, C., Shi, H., Zhang, C., Xi, T., Huang, J., Fang, W., Ni, Z., Gu, L., et al. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2657048 · Cited by 2
“31 In addition, it has been reported that PD patients with and without a history of peritonitis have different characteristics of the gut microbiota.”
Combined heat and exercise stress disrupt gut microbiota and promote microbial translocation
Min, L., Ablitip, A., Wang, Q. Q., Li, T., Di, Q., Ma, X., & Fang, W. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1779295 · Cited by 2
Wu, Y., Dou, J., Liu, M., Peng, S., & Li, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749185 · Cited by 4
The impact of gut microbiome on intrahepatic cholestasis of pregnancy—systematic literature review
Donzé, F. J., Eli, N., Simone, N. D., Cavegn, B. B., & Mueller, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1859397 · Cited by 2
“Dysfunction of intestinal barrier are involved and contributed to establish several metabolic diseases, including type 2 diabetes mellitus (44) inflammatory bowel disease (45) and metabolic syndrome (28).”
The interplay between the microbiome and immune cells in metabolic homeostasis and disease
Shapiro, H., Jickeli, B., Niv, I., Ernan, B., & Elinav, E. (2026) · Cell Metabolism · doi:10.1016/j.cmet.2026.06.004 · Cited by 7
Self-citationThe Postprandial Chronobiome in Interorgan Glucose Homeostasis
Božić, J., Šantić, R., & Kumrić, M. (2026) · Comprehensive physiology · doi:10.1002/cph4.70236 · Cited by 2
“…completing a feedback loop relevant to T2D progression: GLUT2-dependent transcriptional reprogramming of intestinal epithelial cells retracts tight junctions and increases paracellular permeability, and in humans HbA1c correlates with systemic influx of microbial products (Thaiss et al. 2018).”
Schneider, K. M., & Trautwein, C. (2020) · Wiener klinisches Magazin · doi:10.1007/s00740-020-00353-1 · Cited by 3
“Wie neueste Forschungsarbeiten demonstrieren, scheint Hyperglykämie selbst die Funktion der intestinalen Barriere entscheidend zu beeinflussen [37].”
BackgroundMétabolisme du tryptophane et interactions avec le microbiote intestinal
Laurans, L., & Taleb, S. (2021) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2021.01.001 · Cited by 3
Silva, T. F., Gonçalves, M. D., Concato, V. M., Bortoleti, B. T. D. S., Tomiotto‐Pellissier, F., Sanfelice, R. A., Rodrigues, A. C. J., Detoni, M. B., Simão, A. N. C., Custódio, L. A., et al. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.07.001 · Cited by 2
Wu, X., Wang, Y., Du, X., Liu, Y., Gao, Y., Tuo, Y., & Mu, G. (2022) · Food Bioscience · doi:10.1016/j.fbio.2022.101762 · Cited by 2
Corrêa, C. E. B., Coutinho, R. M. C., Picoli, M. E. F. D. S., & Ananias, F. (2023) · Concilium · doi:10.53660/clm-1990-23n58 · Cited by 2
Wang, M., Li, Y., Yang, S., & Wei, P. Y. (2024) · Journal of Medicinal Food · doi:10.1089/jmf.2023.k.0093 · Cited by 2
“29 The destruction of intestinal mucosal barrier function in patients with diabetes, as well as elevated glucose levels, leads to a decrease in the integrity of the intercellular junctions, increasing intestinal epithelial cell permeability, which affects the absorption of antigens, and ultimately…”
Gut microbiota and kidney diseases. Literature review
Shutov, E. V., Bolshakov, S. A., Makarova, T., Fedoseeva, I., Teplyuk, D. A., Pavlov, C. S., & Sorokoletov, S. M. (2024) · Nephrology and Dialysis · doi:10.28996/2618-9801-2024-3-283-302 · Cited by 3
Dietary prevention of antibiotic‐induced dysbiosis and mortality upon aging in mice
Smith, K., Francisco, S. G., Zhu, Y., LeRoith, T., Davis, M. L., Crott, J. W., Barger, K., Greenberg, A. S., Smith, D. E., Taylor, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202402262r · Cited by 2
“57,58 Similarly, streptozotocin-induced hyperglycemia increased the severity of antibiotic-induced changes in gut microbiome composition and function as well as susceptibility to enteric infection.”
Hadefi, A., Leprovots, M., Dinsart, G., Marefati, M., Vermeersch, M., Monteyne, D., Pérez-Morga, D. L., Lefort, A., Libert, F., Verset, L., et al. (2024) · Gastro Hep Advances · doi:10.1016/j.gastha.2024.100599 · Cited by 2
“…fi cally, recent fi ndings have shown that excessive fructose intake and high-fat diets (saturated fat) promote intestinal barrier ’ s disruption, 6 increase villus length and therefore increase nutrient absorption and adiposity, 7,8 and reduce mucous layer ’ s thickness, 9 overall leading to…”
Brown, R. E., Barko, P. C., Romero, J. D. J. R., Williams, D. A., Gochenauer, A. E., Nguyen-Edquilang, J., Suchodolski, J. S., Pilla, R., Ganz, H., Lopez-Villalobos, N., et al. (2025) · Journal of Small Animal Practice · doi:10.1111/jsap.13865 · Cited by 2
“Independently, hyperglycaemia also has a direct negative effect on the integrity of the gut epithelial tight junctions (Thaiss et al., 2018).”
Zwicky, S. N., Mordasini, L., Spari, D., Yılmaz, B., & Beldi, G. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06462-x · Cited by 2
Adams, G. G. (2021) · International Journal of Diabetes and Endocrinology · doi:10.46715/ijde2021.02.1000110 · Cited by 2
Minimally Invasive Image-Guided Gut Transport Function Measurement Probe
Otuya, D. O., Gavgiotaki, E., Carlson, C. J., Shi, S. Q. Z., Lee, A. J., Krall, A. A., Chung, A. S., Grant, C. N., Bhat, N. G. M., Choy, P., et al. (2021) · Frontiers in Physics · doi:10.3389/fphy.2021.735645 · Cited by 2
“Changes in intestinal permeability have been specifically linked to a wide variety of diseases and syndromes including celiac disease [5], type II diabetes (T2D) [5–8]; inflammatory bowel disease (IBD) [9–11], irritable bowel syndrome [12,13], environmental enteric dysfunction [14,15], obesity [16,17], chronic fatigue…”
BackgroundCao, M., Zhu, Y., Chen, Y., & Jin, J. (2022) · Nutrients · doi:10.3390/nu14030406 · Cited by 2
“Moreover, SSB-related hyperglycemia is associated with infection and its clinically related symptoms [23].”
BackgroundCharifi, W., Fauveau, V., Francese, L., Grosfeld, A., Gall, M. L., Ourabah, S., Ellero‐Simatos, S., Viel, T., Caüzac, M., Gueddouri, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.18.444615 · Cited by 2
Self-citationA bioenergetic basis for multiorgan dysfunction in sepsisPreprint
Jentho, E., Ademolue, T. W., Sengers, H. P., Butler, J. M., Xu, L., Rastogi, S., Kitoko, J. Z., Pagnotta, S. E., Drotleff, B., Faísca, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.12.659280 · Cited by 2
Toll-like Receptor 4 Contributes to PCOS-like Metabolic and Reproductive PathogenesisPreprint
Wiggins, K. D., Mundo, Z. D. D., Angulo, J. A. A., Naidu, N., Saba, A., Garcia, C., Nguyen, C. M., Ujagar, N. S., Torre, J.-J. D. L., Robles, G. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.16.682907 · Cited by 2
Hasan, M. K. C., Razali, N. R., Isa, M., Ibrahim, M., & Muhammad, H. (2021) · INTERNATIONAL JOURNAL OF CARE SCHOLARS · doi:10.31436/ijcs.v4i1.171 · Cited by 1
RELATIONSHIP OF LEAKY GUT SYNDROME AND METABOLIC SYNDROME
Tolloto, G. H. V., & Saragiotto, L. (2022) · Health and Society · doi:10.51249/hs.v2i01.661 · Cited by 1
The Role Microbiome and Oncolytic Viruses Play in Controlling Cancer
Atiatorme, E., Osafo, R., & Nyarko, S. (2022) · Journal of Cancer and Tumor International · doi:10.9734/jcti/2022/v12i130169 · Cited by 1
“serum from healthy individuals contain stimuli capable of activating a range of TLR and NOD receptors [53].”
BackgroundTulod, J. Z., Witman, N. D., Grond, K., Duddleston, K. N., & Kurtz, C. C. (2023) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00078.2023 · Cited by 1
Yang, J., & Li, S. (2024) · Journal of Biomaterials Applications · doi:10.1177/08853282241270963 · Cited by 1
RetractedWu, W., Tong, H.-M., Li, Y., & Cui, J. (2025) · Medicine · doi:10.1097/md.0000000000041532 · Cited by 1
Ye, S., Fu, T., Tu, Y., Wellens, J., Chen, X., Larsson, S. C., Sun, J., Dan, L., Wang, X., Chen, J., et al. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf036 · Cited by 1
Peanut skin procyanidins regulate insulin signaling and hepatic metabolism in diabetic mice
Liu, M., Zhang, H., Ju, T., Willing, B. P., Chen, W., Liu, J., Lü, Q., & Liu, R. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250411 · Cited by 1
Zou, L., Fu, X., Huang, J., Liu, W., Zhou, L., Zhou, Y., Lin, Y., & Liu, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321857 · Cited by 1
“Their overcon-sumption can trigger serious health issues, including organ dysfunction and chronic diseases [10].”
Rechl, M. L., Balika, E., Oberle, S., Preinfalk, V., Stadlmayr, S., Rasztovits, J., Ley, J. P., & Lieder, B. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c02797 · Cited by 1
Schmelter, F., Schröder, T., Laumonnier, Y., Bischoff, S. C., Derer, S., Jensen, B. A. H., & Sina, C. (2025) · Gut · doi:10.1136/gutjnl-2025-336797 · Cited by 1
“Importantly, hyperglycaemia itself drives intestinal barrier dysfunction and increases infection risk, 5 providing direct mechanistic support for glucose-targeted interventions in functional GI disorders.”
Uramoto, S., Tanaka, S., Itai, S., Muramatsu, J., Arai, D., Tsukada, K., Abe, T., Toyohara, T., & Onoe, H. (2025) · Lab on a Chip · doi:10.1039/d5lc00766f · Cited by 1
Singla, S., & Jena, G. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04907-0 · Cited by 1
Role of neddylation in diabetes metabolism: potential therapeutic target
Li, H., Zeng, R., Liu, J., & Wang, H. (2026) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01837-9 · Cited by 1
Microbial activation of the GLP-2R mitigates gastrointestinal inflammation
Yang-Jensen, S. K., Choi, B. S.-Y., Nägele, N. S., Pærregaard, S. I., Neven, K., Savickas, V., Gupta, N., Modvig, I. M., Holm, J. B., Kristiansen, K., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68551-9 · Cited by 1
Chen, Q., Mei, H., Fang, M., Cui, Y., Rong, T. Z., Deng, D., Tian, Z., Song, M., Li, Z., Liu, Z., et al. (2026) · Food Research International · doi:10.1016/j.foodres.2026.118686 · Cited by 1
The Regulatory Role of FABP4 in Microbiome–Brain–Gut Communication Under High-Fat-Diet Conditions
Smolińska, K., Tomaszewska, E., Hułas‐Stasiak, M., Muszyński, S., Szopa, A., Serefko, A., & Dobrowolski, P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27052430 · Cited by 1
“Western diets rich in saturated fats shift the microbiome towards pro-inflammatory profiles, increasing endotoxin exposure and compromising gut barrier integrity [23,24].”
Chen, Y., Ru, G., Wang, T., & Liu, J. (2026) · American Journal of Rhinology and Allergy · doi:10.1177/19458924261444416 · Cited by 1
“35,36 Concurrently, obesity promotes tissue remodeling and alters the local tissue microenvironment, increasing susceptibility to chronic in fl ammation and facilitating in fl ammatory cell recruitment.”
Capsaicin ameliorates glycemic levels via gut microbiota-derived 5-aminolevulinic acid in mice
Fang, Q., Huang, S., Zhang, C., Li, M. Y., Ye, Z., Guo, H., Xiao, M., Wang, S., Yu, L., Zhang, H., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02415-8 · Cited by 1
“Diet is a major determinant of glycemic control and gut microbiota composition, with dietary interventions influencing glycemic metabolism through coordinated modulation of microbial composition and function [7].”
Son, J. Y., Do, Y., Seo, J., & Choi, J. (2026) · Nutrients · doi:10.3390/nu18091442 · Cited by 2
“Previous studies have shown that barrier disruption facilitates LPS translocation and systemic immune activation, with evidence from both human-related and animal models demonstrating movement of microbial components beyond the gut environment [158,159].”
Sharma, H., Tyagi, S., Verma, S., Ghosh, S., & Pande, M. S. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113291 · Cited by 1
Drai, E., Nahmias, D., Hermano, E., Yifrach, A., Chen, O., Maimon, O., Popovtzer, A., Peretz, T., Meirovitz, A., & Elkin, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104338 · Cited by 1
“In ME, small quantities of endotoxin are translocated from the gut lumen to the circulation due to impaired intestinal permeability [6,9–11].”
D’Alessio, D. A., & Campbell, J. E. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70894 · Cited by 1
Yeh, K.-H., Ahuja, D., Patel, S. B., Xu, R., Park, S.-K., Gold, S. L., Ramos, G. P., Malik, T., Kaur, M., Bering, J., et al. (2026) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2026.06.008 · Cited by 1
Barrier restoration as a therapeutic strategy for disorders of gut–brain interaction
Britton, T. A., & Grover, M. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00081-6 · Cited by 1
Gut permeability and endotoxemia in obesity
Fajkić, A., Belančić, A., Meštrović, T., & Lam, Y. W. (2026) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2026.102123 · Cited by 1
Wang, L., Fang, Y., Zhang, S., Lei, P., Ma, J., Jin, L., Wang, W. X., Yang, Q., Wang, Y., Zhao, C., et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124486 · Cited by 1
Early glucose and sodium trajectories and short-term outcomes in extremely preterm infants
Gialamas, S. P., Naseh, N., Groth, E., Olsson, K., Ågren, J., & Sindelar, R. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1878551 · Cited by 1
Pharmacomicrobiomics in metabolic syndrome and type 2 diabetes: the microbiome–drug–host triad
Strilić, D., Stanimirov, B., Pavlović, N., Lazarević, S., Mikov, M., Stanivukovic, T., & Đanić, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1831882 · Cited by 1
“…mechanism: an altered microbial profile in T2DM may drive dysglycemia, arise as a consequence of the metabolic milieu, for example, through hyperglycemia-induced barrier dysfunction, or simply mark shared upstream determinants such as diet, adiposity, and medication exposure (Thaiss et al., 2018).”
Microbiome Composition and Circadian Rhythm Disruption Alters Epithelial Barrier Integrity
Pinker, E. Y., & Tuganbaev, T. (2021) · Columbia Undergraduate Science Journal · doi:10.52214/cusj.v15i1.7408 · Cited by 1
“tinal barrier, specifically its state of permeability [27].”
BackgroundКох, Н. В., Schreiner, E. V., Voronina, E. N., Kovaleva, A. Y., & Израйлевна, Л. Г. (2021) · Russian Pediatric Journal · doi:10.15690/rpj.v2i1.2189 · Cited by 1
Markers of Bacterial Translocation in Type 2 Diabetes Mellitus
Meheissen, M. A. (2022) · Biomarkers in disease · doi:10.1007/978-3-030-81303-1_49-1 · Cited by 1
Liu, Y., Xiang, X., Zeng, Z., Guo, M., Li, Y., Zhan, Z., Huang, R., Zhao, M., Jin, S., & Song, C. (2024) · International Journal of Food Science & Technology · doi:10.1111/ijfs.17236 · Cited by 1
Post COVID-19 and fungal pathogens coinfection in Africa – Current status and future direction
Ibe, C., & Otu, A. A. (2024) · The Microbe · doi:10.1016/j.microb.2024.100152 · Cited by 1
Zhang, J., He, J., Lu, Y., & Lan, T. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1498207 · Cited by 2
“Third, in fl ammation was a key factor in the relationship between cancer and HFPG. Diabetes and hyperglycemia could alter the composition of gut microbiome, damage the integrity of intestinal barrier, and elevate oxidative stress levels, a key characteristic of chronic in fl ammation (34, 35).”
Huang, C.-X., Wang, K., Ke, Z., Zhang, M., Huang, Q., Tong, C., Yan, C., Song, Z., Xu, J., Jiang, T., et al. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250466 · Cited by 1
Qu, X., Zhao, L., & Kang, C. (2025) · Medicine · doi:10.1097/md.0000000000042773 · Cited by 1
“[23] Further studies are needed to validate the role of diabetes in the prognosis of GI diseases.”
Biber, L., Schart, N., Bosy‐Westphal, A., & Kufer, T. A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1596951 · Cited by 1
“In some recent publications, such assays were used to show an increase in various systemic PRR ligands in high-fat diet fed mice (13) and as markers for small intestine barrier function in mice (21, 22) and men (22).”
Reports from a Healthy Community: the 7th Conference on Beneficial Microbes
Mandel, M. J., Broderick, N. A., Martens, E. C., & Guillemin, K. J. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02562-18 · Cited by 1
“Finally, Elinav shared work showing that the primary effect of hyperglycemia is GLU-2-dependent disruption of intestinal barrier function, which explained the resulting symptoms of increased inflammation and susceptibility to enteric infections (5).”
BackgroundCeliac disease and small-bowel enteropathy – Seeing beyond the haze, the mist and the fog
Marlicz, W. M., & Koulaouzidis, A. (2018) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2018.12.003 · Cited by 1
Defining the role of individual gut commensal microbes and host-microbe interactions
Ju, T. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-fhw9-mj96 · Cited by 1
Lu, X. D., Zhao, M., Duan, Y., Wang, F., & Chen, C. (2020) · doi:10.21203/rs.3.rs-97812/v1 · Cited by 2
“With a deepening understanding of the relationship between the gut microbiota and human health, the gut microbiota has been recognized as a therapeutic target in some diseases, including obesity, enteric disease, ALD, and so on (Sonnenburg and Bäckhed 2016; Thaiss et al. 2018; Desai et al. 2016).”
BackgroundExcess dietary sugar impairs colonic epithelial regeneration in response to damagePreprint
Burr, A. B. P., Ji, J., Ozler, K., Eskiocak, O., Yueh, B., Menk, A. V., Costa, A. S. H., Rittenhouse, N., Marshall, C. W., Chiaranunt, P., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.18.456840 · Cited by 1
“Short-term high sugar diet does not increase blood sugar or intestinal permeability Excess dietary sugar has been linked to systemic diseases, such as diabetes, and elevated blood glucose can lead to impaired intestinal integrity (Thaiss et al., 2018).”
BackgroundDimba, N. R., Mzimela, N., & Khathi, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2852232/v1 · Cited by 1
Liu, J., Wei, X., Dai, Y., Li, G., Zhang, M., Liang, J., Cheng, Y., & Chi, L. (2023) · Research Square · doi:10.21203/rs.3.rs-3266597/v1 · Cited by 1
Different regulatory mechanisms of Na+/ glucose transport in mouse ileum and jejunumPreprint
Chu, F., Chen, X., Wan, H., Dong, H. F., & Xu, F. (2024) · Research Square · doi:10.21203/rs.3.rs-4483264/v1 · Cited by 1
The gut insulin receptor acts as gatekeeper of epithelial barrier integrityPreprint
Sicherre, F., Gueddouri, D., Caüzac, M., Caudron-Hedeline, A., Benhamed, F., Charifi, W., Terris, B., Chassaing, B., Beaudoin, L., Rouland, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.677561 · Cited by 1
“Moreover, restoration of barrier function in mice lacking intestinal GLUT2 or following inhibition of glucose metabolism has demonstrated that hyperglycemia per se disrupts gut integrity via retrograde glucose flux 7 .”
InfluentialType 2 diabetes amplifies environmental Pb toxicity and intergenerational riskPreprint
Zhang, C., Xia, X., Zhang, C., Pei, C., Guo, Z., Li, G., Xu, L., Luo, H., Ma, J., Luo, J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.21.707175 · Cited by 1
Ilchmann-Diounou, H. (2019) · theses.fr (ABES) · doi:10.70675/77d1e895zc1e7z4ff0zab27z0432cc19c25d · Cited by 1
The role of dietary sugars in intestinal homeostasis and microbiota composition
Zhang, X. (2018) · theses.fr (ABES) · doi:10.70675/bad688b4zdd65z4520zb77cz975f29622456 · Cited by 2
Albornoz, S. P. P. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2018.tde-13092018-111209 · Cited by 1
Avaliação do eixo IL-1/IL-1R na comorbidade obesidade e tuberculose
de Oliveira, R. S. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-15102018-113326
12th Roche Diabetes Care Network Meeting: April 11–13, 2019, Copenhagen, Denmark
Parkin, C. G., Zepezauer, C., & Hinzmann, R. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0392
“Most recently, investigators mechanistically linked hyperglycemia and intestinal barrier function with the systemic infectious and inflammatory consequences of obesity and diabetes.(61)”
BackgroundHong, W., Wang, Y., Yu, H., Wei, X., Yu, D., Zhang, C., Tan, N., & Jiang, L. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-01278-2
Schneider, K. M., & Trautwein, C. (2020) · Die Gastroenterologie · doi:10.1007/s11377-019-00402-0 · Cited by 1
Metadata
- Authors
- Thaiss, C. A., Levy, M., Grosheva, I., Zheng, D., Soffer, E., Blacher, E., Braverman, S., Tengeler, A. C., Barak, O., Elazar, M., Ben-Zeev, R., Lehavi-Regev, D., Katz, M. N., Pevsner-Fischer, M., Gertler, A., Halpern, Z., Harmelin, A., Aamar, S., Serradas, P., Grosfeld, A., Shapiro, H., Geiger, B., & Elinav, E.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.
- Tel Aviv Sourasky Medical Center (IL)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Elinav, Eran
- ORCID
- Venue
- Science
- Published
- 2018-03-23
- Volume
- 359
- Issue
- 6382
- Pages
- 1376-1383
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2794419196
- Cited by
- 942
- References
- 56
- Citations by year
- 2026: 91 · 2025: 134 · 2024: 129 · 2023: 102 · 2022: 142 · 2021: 126 · 2020: 102 · 2019: 74 · 2018: 38
- FWCI
- 30.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- Bill & Melinda Gates Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- hyperglycemia, intestinal barrier dysfunction, gastrointestinal infections, obesity, diabetes mellitus, GLUT2, intestinal epithelial cells, tight junctions, adherens junctions, intestinal permeability, microbial translocation, HbA1c, glycemic control, gut microbiota, systemic inflammation
- MeSH terms
- Gastrointestinal Microbiome, Animals, Blood Glucose, Diabetes Mellitus, Experimental, Escherichia coli Infections, Glucose, Humans, Hyperglycemia, Intestinal Diseases, Intestinal Mucosa, Mice, Inbred Strains, Obesity, Permeability, Streptozocin, Gene Deletion, Caco-2 Cells, Citrobacter rodentium, Glucose Transporter Type 2, Mice, Enteropathogenic Escherichia coli, Receptors, Leptin, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.